Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nuvectis Pharma, Inc. | 124,760 | reported | 05 Nov 2025 | tx 7+107,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Nov 2025 | PURCHASE | Nuvectis Pharma, Inc. | 11,000 | 5.84 USD | first after silence |
| 12 Jun 2025 | GRANT_AWARD | Nuvectis Pharma, Inc. | 30,000 | 0.00 USD | |
| 13 Jun 2024 | GRANT_AWARD | Nuvectis Pharma, Inc. | 30,000 | 0.00 USD | |
| 16 Jun 2023 | GRANT_AWARD | Nuvectis Pharma, Inc. | 18,000 | 0.00 USD | |
| 12 May 2022 | PURCHASE | Nuvectis Pharma, Inc. | 1,177 | 15.96 USD | |
| 12 May 2022 | PURCHASE | Nuvectis Pharma, Inc. | 1,823 | 17.47 USD | |
| 01 Apr 2022 | GRANT_AWARD | Nuvectis Pharma, Inc. | 15,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 05 Nov 2025.